Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177

Matthieu Dallons; Esma Alpan; Corentin Schepkens; Vanessa Tagliatti; Jean-Marie Colet

PMC · DOI:10.3390/cells14201574·October 10, 2025

Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177

Matthieu Dallons, Esma Alpan, Corentin Schepkens, Vanessa Tagliatti, Jean-Marie Colet

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Cell lines2

MCF-7— Homo sapiens (Human) · Invasive breast carcinoma of no special type · Cancer cell line H9C2— Rattus norvegicus (Rat) · Spontaneously immortalized cell line

Chemicals1

Doxorubicin

Diseases2

Breast Cancer Cardiotoxicity

Figures1

Click any figure to enlarge with its caption.

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsChemotherapy-induced cardiotoxicity and mitigation · Cancer Treatment and Pharmacology · Cancer-related cognitive impairment studies